Regulation of IGF -1 signaling by microRNAs
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The insulin-like growth factor 1 (IGF-1) signaling pathway regulates critical biological processes including development, homeostasis, and aging. Dysregulation of this pathway has been implicated in a myriad of diseases such as cancers, neurodegenerative diseases, and metabolic disorders, making the IGF-1 signaling pathway a prime target to develop therapeutic and intervention strategies. Recently, small non-coding RNA molecules in ∼22 nucleotide length, microRNAs (miRNAs), have emerged as a new regulator of biological processes in virtually all organ systems and increasing studies are linking altered miRNA function to disease mechanisms. A miRNA binds to 3'UTRs of multiple target genes and coordinately downregulates their expression, thereby exerting a profound influence on gene regulatory networks. Here we review the components of the IGF-1 signaling pathway that are known targets of miRNA regulation, and highlight recent studies that suggest therapeutic potential of these miRNAs against various diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059 · cited 1×
“The other parallel pathway, the RAS-RAF-MAPK, stimulates cell proliferation (Pollak, 2008).”
BackgroundCleavage of Scarecrow-like mRNA Targets Directed by a Class of Arabidopsis miRNA
Llave, C., Xie, Z., Kasschau, K. D., & Carrington, J. C. (2002) · Science · doi:10.1126/science.1076311 · Cited by 1,627 · cited 1×
“…miRNA:mRNA sequence complementarity and negatively affects gene expression either through mRNA cleavage and degradation via the perfect base-pairing with target mRNA or translation repression via imperfect complementation with 3′UTR of target mRNA (Llave et al., 2002; Smith-Vikos and Slack, 2012).”
BackgroundLNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589
Pervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180 · cited 2×
“…cellular mediators, miRNAs can be easily manipulated and therapies based on antimiRs or miRNA mimics are now being developed to repress pathological miRNAs (Elmen et al., 2008; Lanford et al., 2010; Small and Olson, 2011) or to overexpress protective miRNAs (Small and Olson, 2011), respectively.”
BackgroundGene regulation by transcription factors and microRNAs
Hobert, O. (2008) · Science · doi:10.1126/science.1151651 · Cited by 913 · cited 1×
“A miRNA can target multiple mRNAs and one mRNA can be controlled by multiple miRNAs (Hobert, 2008).”
BackgroundMorphogenesis in skin is governed by discrete sets of differentially expressed microRNAs
Yi, R., O'Carroll, D., Pasolli, H. A., Zhang, Z., Dietrich, F. S., Tarakhovsky, A., & Fuchs, E. (2006) · Nature Genetics · doi:10.1038/ng1744 · Cited by 555
Combining two strategies to improve perfusion and drug delivery in solid tumors
Stylianopoulos, T., & Jain, R. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318415110 · Cited by 508 · cited 2×
“…challenges to be addressed, which include but not limited to targeted delivery of oligonucleotides to specific organs, tissues and cell types, poor bioavailability, limited tissue permeability (Stylianopoulos and Jain, 2013), potential drug resistance, and instability (Raemdonck et al., 2008).”
BackgroundWelsh, G. I., Miller, C. M., Loughlin, A. J., & Price, N. T. (1998) · FEBS Letters · doi:10.1016/s0014-5793(97)01548-2 · Cited by 298 · cited 1×
“Phosphorylation of GSK3β by AKT blocks its activity, leading to the dephosphorylation and activation of the eukaryotic translation initiation factor 2B (eIF2B) involved in protein synthesis and cell survival (Welsh et al., 1998).”
BackgroundWang, X., Liu, P., Zhu, H., Xu, Y., Ma, C., Dai, X., Huang, L., Liu, Y., Zhang, L., & Qin, C. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.08.006 · Cited by 271 · cited 2×
“…signaling has been associated with Alzheimer’s disease (AD; Hong and Lee, 1997; Vargas et al., 2011). miR-98 has shown to increase in AD mouse model (Wang et al., 2009) and miR-98 was found to target IGF-1 3′UTR directly leading to the decreased IGF-1 expression at both mRNA and protein levels (Hu…”
BackgroundFunctional recovery with recombinant human IGF1 treatment in a mouse model of Rett syndrome
Castro, J., Garcia, R. I., Kwok, S., Banerjee, A., Petravicz, J., Woodson, J., Mellios, N., Tropea, D., & Sur, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311685111 · Cited by 242 · cited 2×
“Administration of IGF-1 to Mecp2 KO mice rescued disease-related symptoms (Castro et al., 2014).”
Background
Cited by
Developmental and Functional Control of Natural Killer Cells by Cytokines
Wu, Y., Tian, Z., & Wei, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00930 · Cited by 269
Gallagher, E. J., & LeRoith, D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0295-5 · Cited by 241
Leinders, M., Doppler, K., Klein, T., Deckart, M., Rittner, H., Sommer, C., & Üçeyler, N. (2016) · Pain · doi:10.1097/j.pain.0000000000000668 · Cited by 71
Muscle cell communication in development and repair
Demonbreun, A. R., & McNally, E. M. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.03.008 · Cited by 64
Cytoplasmic mRNA turnover and ageing
Borbolis, F., & Syntichaki, P. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.09.006 · Cited by 39
Metadata
- Authors
- Jung, H. J., & Suh, Y.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2015-01-13
- Volume
- 5
- Pages
- 472-472
- ISSN
- 1664-8021 (ISSN-L)
- OpenAlex
- W2051090964
- Cited by
- 117
- References
- 11
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulation of IGF -1 signaling by microRNAs. https://app.cochat.ai/papers/10.3389/fgene.2014.00472
- The paper
- Jung, H. J., & Suh, Y. (2015). Regulation of IGF -1 signaling by microRNAs. Frontiers in Genetics. https://doi.org/10.3389/fgene.2014.00472
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.